To access this element change to forms mode OFF
Grant Award View - GA217928
Clinical Trial of Cannabidiol for Treatment Resistant Anxiety Disorders...
GA ID:
GA217928
Agency:
Department of Health and Aged Care
Approval Date:
4-Nov-2021
Publish Date:
16-Feb-2022
Category:
Health and Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2024
Value (AUD):
$1,745,708.55
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 21/22 1.1 Health Policy Research and Analysis
Grant Program:
Medical Research Future Fund
Grant Activity:
Clinical Trial of Cannabidiol for Treatment Resistant Anxiety Disorders in Youth
Purpose:
Anxiety disorders are the most common psychiatric conditions in youth. With current treatments only around 50% of young people remit from their anxiety disorders. Cannabidiol (CBD) is the major non-intoxicating constituent of cannabis; it has anxiolytic properties and excellent tolerability and safety as demonstrated by our successful pilot study. We now aim to test whether CBD can reduce anxiety severity in youth who did not respond to standard treatments in a larger placebo-controlled study.
GO ID:
GO Title:
MRFF - Clinical Trials Activity Initiative - 2021 Innovative Therapies for Mental Illness - Grant Opportunity
Internal Reference ID:
2021/MRF2014252
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, WA
Postcode:
Multiple
Country:
AUSTRALIA